Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132795 · ClinicalTrials.gov registry record · Phase 2
Using Telephone Technology to Prevent Relapse After Alcoholism Treatment
A Phase 2 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 2
- Development phase
- 158
- Enrollment target
NCT00132795 is a Phase 2 study that has completed, run by University of Vermont. The registered enrollment target is 158 participants.
The verdict
NCT00132795, a Phase 2 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 158 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a telephone based self-help program will prevent relapse among individuals undergoing standard substance abuse treatment.
Interventions
- BEHAVIORAL control group
- BEHAVIORAL Daily monitoring of alcohol & drug use, & therapy skills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2005-05 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00132795
The ClinicalTrials.gov registry entry for NCT00132795 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which control group is the first listed.
NCT00132795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00132795 about?
NCT00132795 is a clinical study titled "Using Telephone Technology to Prevent Relapse After Alcoholism Treatment". The purpose of this study is to determine whether a telephone based self-help program will prevent relapse among individuals undergoing standard substance abuse treatment.
What is the current status of trial NCT00132795?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 158 participants. The study started on 2005-05. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00132795?
The interventions under investigation include: control group (BEHAVIORAL), Daily monitoring of alcohol & drug use, & therapy skills (BEHAVIORAL).
Who is sponsoring clinical trial NCT00132795?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.